Back to top
Send SMS Send Inquiry
Sovihep D Sofosbuvir And Daclatasvir

Sovihep D Sofosbuvir And Daclatasvir

6500 INR/Bottle

Product Details:

  • Molecular Formula Sofosbuvir (400mg) + Velpatasvir (100mg)
  • Grade A
  • Medicine Type Treatment of Chronic hepatitis C virus (HCV) infection
  • Dosage 1 TABLET DAILY
  • Supply Ability : 500 Bottle Per Day
  • Click to view more
X

Price And Quantity

  • 6500 INR/Bottle
  • 1 Bottle

Product Specifications

  • Sofosbuvir (400mg) + Velpatasvir (100mg)
  • A
  • 1 TABLET DAILY
  • Treatment of Chronic hepatitis C virus (HCV) infection

Trade Information

  • Cash Advance (CA), Cash on Delivery (COD)
  • 500 Bottle Per Day
  • 2 Days
  • Contact us for information regarding our sample policy
  • 1*28
  • Asia
  • All India

Product Description

Velasof Tablet is a combination of two antiviral medicines. This prescription medicine is used in the treatment of chronic hepatitis C virus (HCV) infection. It fights against the viruses to resolve the infection.

Velasof Tablet should be taken in the prescribed dose and duration. It can be taken with or without food, but take it at the same time daily. It is advised not to consume more than the recommended dose. It is important to inform your doctor if you have any health conditions such as liver or kidney disease. It is harmful to consume alcohol along with this medicine, so it is advised to limit or avoid alcohol. The course of the medicine should be completed for better results.

The common side effects of this medicine are tiredness and headache. You should drink plenty of fluid and eat a healthy diet to prevent or overcome the side effects. Before taking the medicine, inform your doctor if you are taking any other medicines or supplements.
Enter Buying Requirement Details
Email Id
Mobile number

Other Products in 'Sofosbuvir Tablets' category



PHARMA BROTHERS
B No.F-15, Mahima Palace, Govind Mitra Road, Patna - 800004, Bihar, India
Phone :08035948373
Mr Sanjay Kumar Singh (Partner)
Mobile :08035948373


Send SMS Send Inquiry